Abstract Details
|
Adam De Havenon, MD, FÂé¶¹´«Ã½Ó³»
(Yale University)
PRESENTER |
Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care. |
| Nazanin Sheibani, MD (Tremont) | Dr. Sheibani has nothing to disclose. |
| No disclosure on file | |
| Ka-Ho Wong (U of U Neurology Clinic) | The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association. |
| Nils Petersen, MD, FÂé¶¹´«Ã½Ó³» (Yale University) | The institution of Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Silkroad Medical. Dr. Petersen has received research support from NIH. |